Skip to main content
Stem Cell Research & Therapy logoLink to Stem Cell Research & Therapy
. 2022 Oct 8;13:497. doi: 10.1186/s13287-022-03184-5

Retraction Note: Mesenchymal stem cell-derived exosomal miR-146a reverses diabetic β-cell dedifferentiation

Qin He 1, Jia Song 1, Chen Cui 1, Jinbang Wang 1, Huiqing Hu 1, Xinghong Guo 1, Mengmeng Yang 1, Lingshu Wang 1, Fei Yan 1, Kai Liang 1, Zhaojian Liu 2, Fuqiang Liu 1, Zheng Sun 1, Ming Dong 1,3,4, Xinguo Hou 1,3,4, Li Chen 1,3,4,5,
PMCID: PMC9548202  PMID: 36209137

Retraction Note to: Stem Cell Research & Therapy (2021) 12:449 https://doi.org/10.1186/s13287-021-02371-0

The Editors-in-Chief have retracted this article because there are regions of overlap between Fig. 2A and Fig. 4A. The Editors-in-Chief therefore no longer have confidence in the data presented.

Li Chen does not agree to this retraction. None of the other authors has responded to any correspondence from the publisher about this retraction.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Stem Cell Research & Therapy are provided here courtesy of BMC

RESOURCES